These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 10547427)
61. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes. Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018 [TBL] [Abstract][Full Text] [Related]
62. Recombinant retrovirus-derived virus-like particle-based vaccines induce hepatitis C virus-specific cellular and neutralizing immune responses in mice. Huret C; Desjardins D; Miyalou M; Levacher B; Amadoudji Zin M; Bonduelle O; Combadière B; Dalba C; Klatzmann D; Bellier B Vaccine; 2013 Mar; 31(11):1540-7. PubMed ID: 22634300 [TBL] [Abstract][Full Text] [Related]
63. Induction of human cytomegalovirus (HCMV)-glycoprotein B (gB)-specific neutralizing antibody and phosphoprotein 65 (pp65)-specific cytotoxic T lymphocyte responses by naked DNA immunization. Endresz V; Kari L; Berencsi K; Kari C; Gyulai Z; Jeney C; Pincus S; Rodeck U; Méric C; Plotkin SA; Gönczöl E Vaccine; 1999 Jan; 17(1):50-8. PubMed ID: 10078607 [TBL] [Abstract][Full Text] [Related]
64. Quantification of the number of cytotoxic T cells specific for an immunodominant HCV-specific CTL epitope primed by DNA immunization. Lee AY; Polakos NK; Otten GR; Ulmer JB; Houghton M; Paliard X Vaccine; 2000 Mar; 18(18):1962-8. PubMed ID: 10699347 [TBL] [Abstract][Full Text] [Related]
65. [DNA immunization with a plasmid containing gene of hepatitis C virus protein 5A (NS5A) induces the effective cellular immune response]. Masalova OV; Lesnova EI; Grabovetskiĭ VV; Smirnova OA; Ulanova TI; Burkov AN; Ivanov AV; Zaberezhnyĭ AD; Ataullakhanov RI; Kushch AA Mol Biol (Mosk); 2010; 44(2):275-83. PubMed ID: 20586188 [TBL] [Abstract][Full Text] [Related]
66. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. Cerny A; McHutchison JG; Pasquinelli C; Brown ME; Brothers MA; Grabscheid B; Fowler P; Houghton M; Chisari FV J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734 [TBL] [Abstract][Full Text] [Related]
67. Immune responses to plasmid DNA encoding the hepatitis C virus core protein. Lagging LM; Meyer K; Hoft D; Houghton M; Belshe RB; Ray R J Virol; 1995 Sep; 69(9):5859-63. PubMed ID: 7637033 [TBL] [Abstract][Full Text] [Related]
68. DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. Rodriguez F; An LL; Harkins S; Zhang J; Yokoyama M; Widera G; Fuller JT; Kincaid C; Campbell IL; Whitton JL J Virol; 1998 Jun; 72(6):5174-81. PubMed ID: 9573289 [TBL] [Abstract][Full Text] [Related]
69. Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine. Polakos NK; Drane D; Cox J; Ng P; Selby MJ; Chien D; O'Hagan DT; Houghton M; Paliard X J Immunol; 2001 Mar; 166(5):3589-98. PubMed ID: 11207320 [TBL] [Abstract][Full Text] [Related]
70. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen. Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525 [TBL] [Abstract][Full Text] [Related]
71. Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. Inchauspe G; Vitvitski L; Major ME; Jung G; Spengler U; Maisonnas M; Trepo C DNA Cell Biol; 1997 Feb; 16(2):185-95. PubMed ID: 9052739 [TBL] [Abstract][Full Text] [Related]
72. DNA vaccination for the induction of immune responses against hepatitis C virus proteins. Inchauspé G; Major ME; Nakano I; Vitvitski L; Trépo C Vaccine; 1997 Jun; 15(8):853-6. PubMed ID: 9234532 [TBL] [Abstract][Full Text] [Related]
73. Nucleic acid vaccines against hepatitis viruses. Howard CR; Gray L; D'Mello F; Christopher J; Craske J Dev Biol Stand; 1998; 92():157-62. PubMed ID: 9554270 [TBL] [Abstract][Full Text] [Related]
74. CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization. Encke J; zu Putlitz J; Stremmel W; Wands JR Arch Virol; 2003 Mar; 148(3):435-48. PubMed ID: 12607097 [TBL] [Abstract][Full Text] [Related]
75. Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. Zucchelli S; Capone S; Fattori E; Folgori A; Di Marco A; Casimiro D; Simon AJ; Laufer R; La Monica N; Cortese R; Nicosia A J Virol; 2000 Dec; 74(24):11598-607. PubMed ID: 11090158 [TBL] [Abstract][Full Text] [Related]
76. Synergistic effect of gene-electro transfer and adjuvant cytokines in increasing the potency of hepatitis C virus genetic vaccination. Arcuri M; Cappelletti M; Zampaglione I; Aurisicchio L; Nicosia A; Ciliberto G; Fattori E J Gene Med; 2008 Sep; 10(9):1048-54. PubMed ID: 18655231 [TBL] [Abstract][Full Text] [Related]
77. The roles of MHC class II, CD40, and B7 costimulation in CTL induction by plasmid DNA. Chan K; Lee DJ; Schubert A; Tang CM; Crain B; Schoenberger SP; Corr M J Immunol; 2001 Mar; 166(5):3061-6. PubMed ID: 11207256 [TBL] [Abstract][Full Text] [Related]
78. Enhanced induction of hepatitis C virus-specific cytotoxic T lymphocytes and protective efficacy in mice by DNA vaccination followed by adenovirus boosting in combination with the interleukin-12 expression plasmid. Matsui M; Moriya O; Akatsuka T Vaccine; 2003 Apr; 21(15):1629-39. PubMed ID: 12639484 [TBL] [Abstract][Full Text] [Related]
79. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by immunization with dendritic cells treated with an anthrax toxin fusion protein. Moriya O; Matsui M; Osorio M; Miyazawa H; Rice CM; Feinstone SM; Leppla SH; Keith JM; Akatsuka T Vaccine; 2001 Dec; 20(5-6):789-96. PubMed ID: 11738742 [TBL] [Abstract][Full Text] [Related]
80. M cell DNA vaccination for CTL immunity to HIV. Wang X; Hone DM; Haddad A; Shata MT; Pascual DW J Immunol; 2003 Nov; 171(9):4717-25. PubMed ID: 14568947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]